Position your organization at the forefront of the next wave in bioconjugate innovation
The therapeutic landscape is evolving rapidly. Novel conjugate formats including bispecific ADCs, degrader-antibody conjugates, dual-payload designs, antibody-oligonucleotide conjugates and emerging payload classes are redefining drug development strategies across oncology and beyond. This complexity creates unprecedented demand for agile, science-driven partners who can solve challenges traditional platforms cannot.
What Makes The Novel Conjugates Summit Different?
- Direct Access to Emerging Companies: Engage with CMC leaders, program directors, and scientists shaping next-generation conjugate strategies, many still in exploratory or pre-disclosure stages.
- Explosive Market Growth: Novel ADC formats are growing at a 187% CAGR, driving demand for specialized CDMOs and technology providers.
- Unmatched Networking for Strategic Partnerships: Connect with innovators seeking expertise in linker-payload chemistry, conjugation technologies, analytics, and scalable manufacturing.
- Complexity Creates Opportunity: Bispecifics, dual-payloads, and non-oncology ADCs require custom solutions - not cookie-cutter platforms. This is where your expertise matters.
What to Expect?
Meet New Clients
Connect face-to-face with drug developers who are expanding into the novel conjugates space and actively exploring external partners. Build early relationships with discovery and CMC leaders as they evaluate outsourcing options for bioconjugation and next-generation conjugate programs.
Centre Yourself in Biopharma Dealmaking
Gain visibility among senior stakeholders from R&D, business development, and external innovation teams at leading pharma and biotech companies seeking reliable CDMO partnerships.
Demonstrate Your Expertise
Showcase your bioconjugation and development capabilities through tailored speaking opportunities, technology spotlights, or a high-traffic exhibition booth to position your organization as a trusted partner for novel conjugate manufacturing.
Gain Market Intelligence
Hear directly from emerging and established players as they share their early experiences with bispecific, peptide, and oligonucleotide conjugates, giving you first-hand insights into where future outsourcing demand will grow.
Key Services & Solutions
The community are looking for service and solution providers with capabilities in the below areas but not limited to:
- Bioconjugation expertise for novel payloads
- CDMO services
- CRO services
- Target validation
- AI-enabled precision medicine
- Biomarker discovery & design
- Modeling systems
- Bispecific/ Peptide/ Oligonucleotide synthesis
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverable such as badges, exclusive lunches and drinks receptions to help elevate your brand.
Presenting Slots
Data-driven or case study-led presentations to position yourself as a thought-leader.
Lead
Join expert panels to shape forward-thinking discussions.
Full Delegate List
Gain exclusive access to the Full Delegate List to plan your conversations in advance.
Exhibit
Raise brand awareness and answer questions from prospect customers.
Network
Engage in 1-2-1 conversations with industry or be part of the organized networking options to generate commercial collaborations.
Innovative Networking
Host breakfast, lunches, dinners for drinks receptions to have exclusive time with your target audience.
Champion the Industry
Be part of the bioconjugate community and position yourself as an advocate for innovation and achievements in the bioconjugate space.
Branding
On-site and website branding to highlight your company at the forefront of the bioconjugate field.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Mehmet Gul
Partnerships Director